The Darwin Prospective Melioidosis Study
The Darwin Prospective Melioidosis Study (DPMS) commenced on October 1st, 1989. Over 30 years to September 30th, 2019, there were 1148 individuals with Burkholderia pseudomallei culture-positive melioidosis, of whom 133 (12%) died. Median age was 50 years (IQR 38–60), 48 (4%) study participants were...
Main Author: | |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10137/12313 https://researchers.cdu.edu.au/en/studentTheses/the-darwin-prospective-melioidosis-study %7C Click here for thesis |
id |
ftnorthernterhls:oai:digitallibrary.health.nt.gov.au:10137/12313 |
---|---|
record_format |
openpolar |
spelling |
ftnorthernterhls:oai:digitallibrary.health.nt.gov.au:10137/12313 2023-05-15T16:16:21+02:00 The Darwin Prospective Melioidosis Study Currie BJ 2022-01-20 https://hdl.handle.net/10137/12313 https://researchers.cdu.edu.au/en/studentTheses/the-darwin-prospective-melioidosis-study %7C Click here for thesis English eng https://hdl.handle.net/10137/12313 https://researchers.cdu.edu.au/en/studentTheses/the-darwin-prospective-melioidosis-study %7C Click here for thesis Burkholderia pseudomallei Genome Bacterial Incidence Melioidosis Middle Aged Multilocus Sequence Typing Northern Territory - epidemiology Prospective Studies Risk Factors Whole Genome Sequencing Melioidosis - epidemiology Melioidosis - mortality Thesis 2022 ftnorthernterhls 2022-11-24T20:31:51Z The Darwin Prospective Melioidosis Study (DPMS) commenced on October 1st, 1989. Over 30 years to September 30th, 2019, there were 1148 individuals with Burkholderia pseudomallei culture-positive melioidosis, of whom 133 (12%) died. Median age was 50 years (IQR 38–60), 48 (4%) study participants were children younger than 15 years of age, 721 (63%) were male individuals, and 600 (52%) First Nations Australians. All but 186 (16%) had clinical risk factors, 513 (45%) had diabetes, and 455 (40%) hazardous alcohol use. Only three (2%) of 133 fatalities had no identified clinical risk factor. Of 1148 primary melioidosis presentations, 1013 (88%) were acute (with an incubation period of 1–21 days, median 4 days, IQR 3–7 days), 106 (9%) were chronic (defined as symptoms for ≥ 2months), and 29 (3%) were considered to be infection activations from latency. 60 (5%) individuals had one or more recurrences of melioidosis, of whom 44 individuals had a relapse and 20 individuals had a new infection, making a total of 1212 episodes of melioidosis over the 30 years. Pneumonia was the most common presentation occurring in 595 (52%) patients. Bacteraemia occurred in 633 (56%) of 1135 patients, septic shock in 240 (21%) patients, and 180 (16%) patients required mechanical ventilation. Cases correlated with rainfall, with 80% of infections occurring during the wet season (November to April). Median annual incidence was 20·5 cases per 100,000 people; the highest annual incidence in First Nations Australians was 103·6 per 100,000 in 2011–12. Over the 30 years, annual incidences increased, as did the proportion of patients with diabetes, although mortality decreased to 17 (6%) of 278 patients over the last 5 years. Genotyping of B. pseudomallei at Menzies School of Health Research evolved from ribotyping in the early days, to pulsed–field gel electrophoresis and BOX–PCR. With the advent of direct genome sequencing, Menzies embraced multilocus sequence typing (MLST) and more recently analysis of whole genome sequencing of B. ... Thesis First Nations Northern Territory Government Health Library Services ePublications Menzies ENVELOPE(61.911,61.911,-73.437,-73.437) |
institution |
Open Polar |
collection |
Northern Territory Government Health Library Services ePublications |
op_collection_id |
ftnorthernterhls |
language |
English |
topic |
Burkholderia pseudomallei Genome Bacterial Incidence Melioidosis Middle Aged Multilocus Sequence Typing Northern Territory - epidemiology Prospective Studies Risk Factors Whole Genome Sequencing Melioidosis - epidemiology Melioidosis - mortality |
spellingShingle |
Burkholderia pseudomallei Genome Bacterial Incidence Melioidosis Middle Aged Multilocus Sequence Typing Northern Territory - epidemiology Prospective Studies Risk Factors Whole Genome Sequencing Melioidosis - epidemiology Melioidosis - mortality Currie BJ The Darwin Prospective Melioidosis Study |
topic_facet |
Burkholderia pseudomallei Genome Bacterial Incidence Melioidosis Middle Aged Multilocus Sequence Typing Northern Territory - epidemiology Prospective Studies Risk Factors Whole Genome Sequencing Melioidosis - epidemiology Melioidosis - mortality |
description |
The Darwin Prospective Melioidosis Study (DPMS) commenced on October 1st, 1989. Over 30 years to September 30th, 2019, there were 1148 individuals with Burkholderia pseudomallei culture-positive melioidosis, of whom 133 (12%) died. Median age was 50 years (IQR 38–60), 48 (4%) study participants were children younger than 15 years of age, 721 (63%) were male individuals, and 600 (52%) First Nations Australians. All but 186 (16%) had clinical risk factors, 513 (45%) had diabetes, and 455 (40%) hazardous alcohol use. Only three (2%) of 133 fatalities had no identified clinical risk factor. Of 1148 primary melioidosis presentations, 1013 (88%) were acute (with an incubation period of 1–21 days, median 4 days, IQR 3–7 days), 106 (9%) were chronic (defined as symptoms for ≥ 2months), and 29 (3%) were considered to be infection activations from latency. 60 (5%) individuals had one or more recurrences of melioidosis, of whom 44 individuals had a relapse and 20 individuals had a new infection, making a total of 1212 episodes of melioidosis over the 30 years. Pneumonia was the most common presentation occurring in 595 (52%) patients. Bacteraemia occurred in 633 (56%) of 1135 patients, septic shock in 240 (21%) patients, and 180 (16%) patients required mechanical ventilation. Cases correlated with rainfall, with 80% of infections occurring during the wet season (November to April). Median annual incidence was 20·5 cases per 100,000 people; the highest annual incidence in First Nations Australians was 103·6 per 100,000 in 2011–12. Over the 30 years, annual incidences increased, as did the proportion of patients with diabetes, although mortality decreased to 17 (6%) of 278 patients over the last 5 years. Genotyping of B. pseudomallei at Menzies School of Health Research evolved from ribotyping in the early days, to pulsed–field gel electrophoresis and BOX–PCR. With the advent of direct genome sequencing, Menzies embraced multilocus sequence typing (MLST) and more recently analysis of whole genome sequencing of B. ... |
format |
Thesis |
author |
Currie BJ |
author_facet |
Currie BJ |
author_sort |
Currie BJ |
title |
The Darwin Prospective Melioidosis Study |
title_short |
The Darwin Prospective Melioidosis Study |
title_full |
The Darwin Prospective Melioidosis Study |
title_fullStr |
The Darwin Prospective Melioidosis Study |
title_full_unstemmed |
The Darwin Prospective Melioidosis Study |
title_sort |
darwin prospective melioidosis study |
publishDate |
2022 |
url |
https://hdl.handle.net/10137/12313 https://researchers.cdu.edu.au/en/studentTheses/the-darwin-prospective-melioidosis-study %7C Click here for thesis |
long_lat |
ENVELOPE(61.911,61.911,-73.437,-73.437) |
geographic |
Menzies |
geographic_facet |
Menzies |
genre |
First Nations |
genre_facet |
First Nations |
op_relation |
https://hdl.handle.net/10137/12313 https://researchers.cdu.edu.au/en/studentTheses/the-darwin-prospective-melioidosis-study %7C Click here for thesis |
_version_ |
1766002207075860480 |